SCHEMBL16900618

SCHEMBL16900618

CC1(C)c2ccccc2-c2cc3c(cc21)N(c1ccccc1)c1ccc(N2c4ccccc4C(C)(C)c4ccccc42)cc1C3(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 11/20 0.43
ALDH1A1 P00352 4/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
GAA P10253 2/20 0.32
CES2 O00748 1/20 0.32
BCHE P06276 1/20 0.32
CES1 P23141 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ITGB2 P05107 1/20 0.31
ICAM1 P05362 1/20 0.31
ITGAL P20701 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2D6 P10635 2/20 0.31
AR P10275 1/20 0.31
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
THPO P40225 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16900628 1.00 PGR (0.43) PGRALDH1A1KMT2AMEN1GAA
SCHEMBL15118512 0.95 PGR (0.47) PGRALDH1A1KMT2AMEN1GAA
SCHEMBL16900617 0.94 PGR (0.39) PGRALDH1A1KMT2AMEN1AR
SCHEMBL12109192 0.93 PGR (0.38) PGRALDH1A1KMT2AMEN1GAA
SCHEMBL16900616 0.91 PGR (0.40) PGRALDH1A1KMT2AMEN1AR
SCHEMBL16900626 0.91 PGR (0.42) PGRALDH1A1KMT2AMEN1GAA
SCHEMBL13231477 0.91 PGR (0.43) PGRALDH1A1KMT2AMEN1GAA
SCHEMBL12109104 0.90 PGR (0.43) PGRALDH1A1KMT2AMEN1GAA
SCHEMBL12109060 0.90 PGR (0.43) PGRALDH1A1KMT2AMEN1GAA
SCHEMBL16900610 0.90 PGR (0.39) PGRALDH1A1KMT2AMEN1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150249218-A1 COMPOUND HAVING INDENOACRIDAN RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2015-09-03 US disclosed
US-20150249218-A1 COMPOUND HAVING INDENOACRIDAN RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2015-09-03 US disclosed
EP-2894155-A1 COMPOUND HAVING INDENO ACRIDAN RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENCE ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2015-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150249218-A1 COMPOUND HAVING INDENOACRIDAN RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE KCNH2, KCNH3, INHA PGR 474/4885ALDH1A1 92/4885KMT2A 3818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.